Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marianna Riekkinen"'
Autor:
Jenni Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi Kuivanen, Sari H. Pakkanen, Sointu Mero, Anu Patjas, Marianna Riekkinen, Anu Kantele, Visa Nurmi, Klaus Hedman, Jussi Hepojoki, Tarja Sironen, Eili Huhtamo, Olli Vapalahti
Publikováno v:
Viruses, Vol 13, Iss 6, p 996 (2021)
Increasing evidence suggests that some newly emerged SARS-CoV-2 variants of concern (VoCs) resist neutralization by antibodies elicited by the early-pandemic wild-type virus. We applied neutralization tests to paired recoveree sera (n = 38) using cli
Externí odkaz:
https://doaj.org/article/3e8bbfdb48f44d629fec817f55df98c9
Autor:
Anu Kantele, Marianna Riekkinen, T Sakari Jokiranta, Sari H Pakkanen, Jukka-Pekka Pietilä, Anu Patjas, Mari Eriksson, Tamim Khawaja, Peter Klemets, Kati Marttinen, Heli Siikamäki, Anna Lundgren, Jan Holmgren, Agneta Lissmats, Nils Carlin, Ann-Mari Svennerholm
Publikováno v:
Journal of Travel Medicine.
Background No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in low- and middle-income countries and foreign travellers alike. ETVAX®, a multivalent oral whole-ce
Autor:
Ruut Uusitalo, Olli Vapalahti, Jussi Hepojoki, Anu Patjas, Anu Kantele, Sointu Mero, Marianna Riekkinen, Tarja Sironen, Eili Huhtamo, Klaus Hedman, Jenni Virtanen, Suvi Kuivanen, Visa Nurmi, Sari H. Pakkanen, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura
Publikováno v:
Viruses
Volume 13
Issue 6
Viruses, Vol 13, Iss 996, p 996 (2021)
Volume 13
Issue 6
Viruses, Vol 13, Iss 996, p 996 (2021)
Increasing evidence suggests that some newly emerged SARS-CoV-2 variants of concern (VoCs) resist neutralization by antibodies elicited by the early-pandemic wild-type virus. We applied neutralization tests to paired recoveree sera (n = 38) using cli
Autor:
Kirsi Aaltonen, Olli Vapalahti, Anu Patjas, Anu Kantele, Sari H. Pakkanen, Marianna Riekkinen, Essi M. Korhonen, Tarja Sironen, Eili Huhtamo, Teemu Smura, Jenni Virtanen, Suvi Kuivanen, Ruut Uusitalo, Sointu Mero, Jussi Hepojoki, Klaus Hedman, Visa Nurmi
SARS-CoV-2 infection raises neutralizing antibodies (NAbs). While studies have shown differing NAb kinetics, they generally point to the antibody arm of immunity providing most recoverees protection against contemporary strains. However, the effect a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00a5d8c444ff2c46404c9445000efbe8
https://doi.org/10.21203/rs.3.rs-279522/v1
https://doi.org/10.21203/rs.3.rs-279522/v1